Additional file 1 of Construction and validation of a prognostic nomogram for predicting the survival of HIV/AIDS adults who received antiretroviral therapy: a cohort between 2003 and 2019 in Nanjing

Additional file 1: Supplementary data. Raw data of HIV/AIDS patients used and analyzed in current study. Note: Variable names and values are described as follows. Infection route (1 = Homosexual transmission, 2 = Heterosexual transmission, 3 = Other transmission); Gender (1 = Male, 2 = Female); Marital status (1 = Unmarried, 2 = Married); Art = time of initiating antiretroviral therapy; TB = tuberculosis (0 = No, 1 = Yes); Continuous diarrhea (0 = No, 1 = Yes); Continuous or intermittent fever (0 = No, 1 = Yes); Shingles (0 = No, 1 = Yes); WHO clinical stage (1 = stage I or II, 2 = stage III, 3 = stage IV); ALT = alanine aminotransferase; AST = aspartate aminotransferase; BMI = body mass index; CD4 = CD4 cell count; WBC = white blood cell; PLT = blood platelet; HB = hemoglobin; CR = creatinine; TG = triglyceride; TC = total cholesterol; FBG = fasting blood glucose; TBIL = total bilirubin; HBV = Hepatitis B Virus (0 = Negative, 1 = Positive); HCV = Hepatitis C Virus (0 = Negative, 1 = Positive); Status = survival status at the last follow-up Status (0 = alive, 1 = dead); End = observation end point.